Renaissance Technologies’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-352,100
| Closed | -$76.4M | – | 3929 |
|
|
2021
Q1 | $76.4M | Buy |
352,100
+196,997
| +127% | +$37M | 0.1% | 223 |
|
|
2020
Q4 | $17.9M | Buy |
155,103
+69,001
| +80% | +$7.73M | 0.02% | 818 |
|
|
2020
Q3 | $8.38M | Buy |
+86,102
| New | +$9.91M | 0.01% | 1261 |
|
|
2020
Q1 | – | Sell |
-250,171
| Closed | -$26.2M | – | 3964 |
|
|
2019
Q4 | $26.2M | Sell |
250,171
-49,829
| -17% | -$5.59M | 0.02% | 852 |
|
|
2019
Q3 | $34.5M | Buy |
+300,000
| New | +$45.5M | 0.03% | 665 |
|
|
2018
Q4 | – | Sell |
-16,400
| Closed | -$2.83M | – | 3725 |
|
|
2018
Q3 | $2.83M | Sell |
16,400
-90,400
| -85% | -$13M | ﹤0.01% | 2109 |
|
|
2018
Q2 | $14.9M | Buy |
+106,800
| New | +$15.2M | 0.02% | 1113 |
|
|
2018
Q1 | – | Sell |
-16,820
| Closed | -$2.22M | – | 3667 |
|
|
2017
Q4 | $2.22M | Buy |
+16,820
| New | +$1.98M | ﹤0.01% | 2286 |
|
|
2017
Q3 | – | Sell |
-84,000
| Closed | -$8.42M | – | 3450 |
|
|
2017
Q2 | $8.42M | Sell |
84,000
-6,200
| -7% | -$667K | 0.01% | 1386 |
|
|
2017
Q1 | $10.9M | Buy |
+90,200
| New | +$11.1M | 0.02% | 1173 |
|
|
2016
Q2 | – | Sell |
-179,400
| Closed | -$12.9M | – | 3583 |
|
|
2016
Q1 | $12.9M | Buy |
179,400
+28,100
| +19% | +$1.54M | 0.02% | 959 |
|
|
2015
Q4 | $10.5M | Buy |
151,300
+140,800
| +1,341% | +$11.5M | 0.02% | 955 |
|
|
2015
Q3 | $959K | Buy |
+10,500
| New | +$1.17M | ﹤0.01% | 2409 |
|
|
2014
Q1 | – | Sell |
-5,100
| Closed | -$212K | – | 3086 |
|
|
2013
Q4 | $212K | Buy |
+5,100
| New | +$161K | ﹤0.01% | 2595 |
|
Other funds holding GWPH
Renaissance Technologies's GWPH Position: Q2 2021 in Review
Renaissance Technologies sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 352,100 shares — an estimated $76.4M sold.
Renaissance Technologies first reported a position in GWPH in Q4 2013 and held it in 14 quarters. The position peaked at $76.4M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- Renaissance Technologies reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- Renaissance Technologies sold 352,100 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $76.4M.
- Renaissance Technologies first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2013 and held it in 14 quarters.
- Renaissance Technologies's GW Pharmaceuticals Plc American Depositary Shares position peaked at $76.4M in Q1 2021.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on Renaissance Technologies's 13F filing for Q2 2021, filed 13 Aug 2021.